UP!
| 2016-03-06 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2016-03-05 | Reiterated Rating | Piper Jaffray | Buy | |
| 2016-03-05 | Reiterated Rating | Piper Jaffray Cos. | Buy | |
| 2016-03-04 | Reiterated Rating | BTIG Research | Hold | |
| 2016-03-04 | Boost Price Target | Piper Jaffray | Overweight | $4.00 to $10.00 |
| 2016-03-04 | Downgrade | Oppenheimer | Outperform to Market Perform | |
| 2016-03-04 | Downgrade | Oppenheimer Holdings Inc. | Outperform to Market Perform | |
| 2015-11-10 | Reiterated Rating | Oppenheimer | Outperform | $10.00 to $9.00 |
| 2015-11-03 | Reiterated Rating | Canaccord Genuity | Buy | $5.00 |
| 2015-11-03 | Reiterated Rating | BTIG Research | Hold | |
| 2015-09-01 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2015-08-05 | Lower Price Target | Oppenheimer | Outperform | $12.00 to $10.00 |
| 2015-08-04 | Reiterated Rating | Canaccord Genuity | Buy | $5.00 |
| 2015-06-24 | Reiterated Rating | Piper Jaffray | Overweight | $10.00 |
| 2015-03-18 | Lower Price Target | Oppenheimer | Outperform | $14.00 to $12.00 |
| 2015-03-18 | Set Price Target | Cowen and Company | Buy | $15.00 to $9.00 |
| 2015-02-22 | Set Price Target | Canaccord Genuity | Buy | $10.00 |
| 2014-03-13 | Reiterated Rating | Summer Street | Buy | |
| 2014-03-12 | Lower Price Target | Canaccord Genuity | $14.75 to $10.00 | |
| 2014-02-20 | Initiated Coverage | BTIG Research | Neutral | |
| 2013-12-02 | Reiterated Rating | Summer Street | Buy | |
| 2013-10-30 | Boost Price Target | Canaccord Genuity | Buy | $12.50 to $14.75 |
| 2013-10-01 | Initiated Coverage | Benchmark Co. | Buy | $16.00 |
| 2016-03-06 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2016-03-05 | Reiterated Rating | Piper Jaffray | Buy | |
| 2016-03-05 | Reiterated Rating | Piper Jaffray Cos. | Buy | |
| 2016-03-04 | Reiterated Rating | BTIG Research | Hold | |
| 2016-03-04 | Boost Price Target | Piper Jaffray | Overweight | $4.00 to $10.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In SSH 0 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Choi Ki Yong | 10.61% (1793109) | SSH / |
| Talu Ventures Pty Ltd | 4.81% (812856) | SSH / |
| Rosa David A Chief Executive Officer | 0.71% (119587) | SSH / |
| ERB JOHN L | 0.68% (115468) | SSH / VASC / |
| BUCKMAN PAUL | 0.34% (56876) | BONE / SSH / |
| O'Dwyer Donal | 0.31% (52466) | SSH / |
| WALLER GREGORY D | 0.27% (46039) | BIOL / ELGX / SSH / |
| WATSON WARREN S | 0.25% (42492) | SSH / |
| Salveson Jon W | 0.25% (42492) | CRY / SSH / |
| MATHIESEN JEFFREY S Chief Financial Officer | 0.22% (37223) | SSH / |
| Peters William S Chief Technical Officer | 0.20% (33309) | SSH / |
| Callinan Nicholas | 0.19% (32147) | SSH / |
| Kridner Debra VP Clinical Research | 0.15% (25500) | SSH / |
| Brown Brian SVP, Technology & Operations | 0.12% (20000) | SSH / |
| Bassett Kevin VP Research, Development | 0.06% (10426) | SSH / |
| Yearick Jim VP of Marketing and Sales | 0.06% (10153) | SSH / |
| Brooke Geoffrey | 0.05% (7855) | SSH / |
| Oleson Kimberly SVP, Clinical Affairs | 0.02% (3810) | SSH / |
| Likens Matthew E. | 0.01% (1437) | SSH / |
| Brandt Steven Frank | 0.01% (1437) | SSH / |
| Wade Molly Vice President | 0.01% (909) | SSH / |
UM